Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (3 ops.)
Latest filing published 21 Sept 2026 for Bolt Biotherapeutics, Inc., €1,699. Read the official filing
Filing timeline
BuySaleSarah Nemec
Insider track record
Disclosed buys
4
Disclosed sells
3
T+90 hit rate
33%
T+90 mean return
-9.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Sarah Nemec: trading record in brief
This profile gathers the share dealings of Sarah Nemec in Bolt Biotherapeutics, Inc. Between 16 December 2024 and 18 September 2026, the trades on record add up to 7 filings.
Market trades split into 4 purchases (€3,974) and 3 sales (€23k). On balance, insiders were net sellers of €19k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 2 purchases and 3 sales on the market.
In size, the median ticket on the buying side is €890. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 21 September 2026: an open-market purchase of €1,699, in Bolt Biotherapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Sarah Nemec
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
509 shares@ US$3.876Common StockSEC:0001193125-26-396892:0
Canonical exit: 3 Sept 2026 (T+90)
843 shares@ US$3.774Common StockSEC:0001193125-26-396892:1
2,922 shares@ US$3.3183Common StockSEC:0001193125-26-396892:2
4,077 shares@ US$3.2364Common StockSEC:0001193125-26-396892:3
125 shares@ US$4.60721.7% of flowCommon StockSEC:0001193125-26-037690:0
Canonical exit: 5 Mar 2026 (T+90)
125 shares@ US$5.49233.7% of flowCommon StockSEC:0001193125-25-250334:0
Canonical exit: 4 Sept 2025 (T+90)
2,500 shares@ US$0.4965100.0% of flowCommon StockSEC:0000950170-25-063846:0
Canonical exit: 16 Mar 2025 (T+90)
7 of 7 declarations
